FDA Clearance Tracker · P150031
VERCISE DEEP BRAIN STIMULATION (DBS)SYSTEM
Last checked: Nov 20, 2026Latest source record: Dec 8, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 8, 2017
Approved
Time to decision
835 days
Received Aug 26, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P150031
- Device name
- VERCISE DEEP BRAIN STIMULATION (DBS)SYSTEM
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Aug 26, 2015
- Decided
- Dec 8, 2017
- Decision
- Approved
- Supplements
- 95 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Vercise DBS System. The device is indicated for use in bilateral stimulation of the subthalamic nucleus (STN) in the treatment of patients with moderate to advanced levodopa-responsive Parkinsons disease (PD), which is not adequately controlled with medication.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NHL. The earliest in FDA's data is P960009-S007, decided Jan 14, 2002.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
- WATCHMAN FLX Left Atrial Appendage (LAA) Closure Technology, WATCHMAN FLX Left Atrial Appendage Closure Device with DeliPMA supplement
P130013-S074 · Decided Jul 16, 2025 · 180 days after receipt · Panel Track
Device type: System, appendage closure, left atrial (NGV) · Cardiology
K243245 · Decided Oct 18, 2024 · 7 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.